GILDALEINE WRIGHT: Open Payments
NPI 1295425601 · OVERLAND PARK, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,240 in 13 payments from 7 companies in 2025. Trend: 2023 $71 · 2024 $878 · 2025 $1,240
Food & beverage: $1,217Education: $24
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 3 | $349 |
| Tris Pharma Inc | 2 | $243 |
| Vanda Pharmaceuticals Inc. | 4 | $210 |
| Neurocrine BioSciences, Inc. | 1 | $138 |
| Otsuka America Pharmaceutical, Inc. | 1 | $124 |
| ABBVIE INC. | 1 | $124 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $52 |
Products named: COBENFY, Dyanavel XR, FANAPT, INGREZZA, ABILIFY MAINTENA, VRAYLAR.
Industry payments across KS — which companies pay providers there.
